TherapeuticsMD, Inc. Lessee, Operating Lease, Liability, to be Paid
TherapeuticsMD, Inc. (TXMD) had Lessee, Operating Lease, Liability, to be Paid of $7.31 million as of 2025-12-31, per its 10-K/A filed 2026-04-01.
Financial Statements › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue · last filed 2026-04-01
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid $7.31M.
- 2024-12-31: Lessee, Operating Lease, Liability, to be Paid $8.95M.
- 2023-12-31: Lessee, Operating Lease, Liability, to be Paid $10.43M.
- 2022-12-31: Lessee, Operating Lease, Liability, to be Paid $11.87M.
| Period end | Lessee, Operating Lease, Liability, to be Paid |
|---|---|
| 2025-12-31 | $7.31M 10-K/A · filed 2026-04-01 |
| 2024-12-31 | $8.95M 10-K · filed 2025-03-27 |
| 2023-12-31 | $10.43M 10-K · filed 2024-03-29 |
| 2022-12-31 | $11.87M 10-K · filed 2023-04-07 |
| 2021-12-31 | $13.28M 10-K · filed 2022-03-23 |
| 2020-12-31 | $15.62M 10-K · filed 2021-03-04 |
| 2020-09-30 | $16.23M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $16.56M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $15.36M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $15.68M 10-K · filed 2020-02-24 |
| 2019-09-30 | $16.00M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $4.60M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $4.89M 10-Q · filed 2019-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |